Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
2 studies found for:    17157662 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Terminated Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Conditions: Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention: Drug: sirolimus
2 Unknown † Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome
Condition: Churg Strauss Syndrome
Intervention: Biological: Mepolizumab
To Top

† Indicates status has not been verified in more than two years